Indication

Primary Ocular Adnexal MALT Lymphoma

2 clinical trials

1 drug

Clinical trial

Safety and Efficacy of Intralesional Rituximab Injection Versus Involved Site Radiation Therapy in Primary Ocular Adnexal MALT Lymphoma: a Multicenter Non-Inferiority Randomized Controlled Trial

Status: Not yet recruiting, Estimated PCD: 2027-10-06

Drug

Clinical trial

Safety and Efficacy of Intralesional Rituximab Injection Versus Involved Site Radiation Therapy in Primary Ocular Adnexal MALT Lymphoma: a Multicenter Randomized Controlled Trial

Status: Recruiting, Estimated PCD: 2027-12-31